- ￥100
- BioporTo
- MON I-1-1
- 2025年07月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态：
IgG
- 保存条件：
-20
- 克隆性：
多克隆
- 规格：
1ml
Product nameAnti-Leptin
Description：Mouse monoclonal antibody, biotinylated
Specificity：ABS 022-11 binds human leptin.
Immunogen：Recombinant human leptin
Application：ELISA
Species reactivity (positive)：Human
Species reactivity (negative)：Not determined
Subclass：IgG1/k
Gene ID：3952
Clone number：11
Epitope：The epitope of ABS 022-11 differs from the epitope of ABS 022-03 but overlaps with the epitope of ABS 022-06
Content
100 µL, 1 mg/mL +/- 15%. See Certificate of Analysis for details.
Purification
Biotinylated
Form
Liquid：Solvent
0.01 M phosphate buffer, pH 7.4, with 0.14 M NaCl and 15 mM sodium azide
Storage
4-8ºC without exposure to light. No precautions necessary during handling.
Target
Leptin, also called obesity factor, is a protein produced by adipose tissue, which has a regulatory influence on food intake, energy metabolism and reproduction. Leptin may also play a role in immune and inflammatory responses and hematopoiesis.
Application 1
ELISA
In sandwich ELISA, bioinylated ABS 022-11 works as a detection antibody with ABS 022-03 as capture antibody.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene
activator inhibitor type-1 [PAI-1]) is an important prognostic factor predicting relapse-free and/or survival in patients with a variety of solid malignant tumors including ovarian cancer; in all cases, high levels of uPA are associated with a poor prognosis (4 -6 ).
as the Northern blot (2 ). Both are, then, often key elements in establishing the identity of nucleic acids of interest. Northern blot analysis was used by us as a tool in order to answer the question whether or not the nuclear transcripitional apparatus of human
The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
技术资料暂无技术资料 索取技术资料
